| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | €8,6923 | -0,10 % | €156,03M | €5,72K | |
BRR ProCap Financial, Inc. Common Stock | €1,6348 | -6,53 % | €155,97M | €817,71K | |
HUMA Humacyte, Inc. Common Stock | €0,56267 | -0,68 % | €155,50M | €4,51M | |
HTLM HomesToLife Ltd Ordinary Shares | €1,6875 | -2,04 % | €155,28M | €15,55K | |
| €47,0168 | -3,19 % | €155,10M | €30,13K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | €14,7128 | -0,65 % | €154,95M | €15,48K | |
PAAC Proem Acquisition Corp I Ordinary Shares | €8,7494 | -0,05 % | €154,83M | €94,04 | |
BNR Burning Rock Biotech Limited American Depositary Shares | €8,1298 | +1,20 % | €154,79M | €1,71K | |
LFCR Lifecore Biomedical, Inc. Common Stock | €3,8759 | -3,71 % | €154,61M | €107,36K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | €8,9560 | +0,00 % | €154,25M | €8,79K | |
| €3,3135 | -8,72 % | €154,14M | €109,09K | |
ECBK ECB Bancorp, Inc. Common Stock | €17,8417 | +2,22 % | €153,95M | €9,38K | |
TNXP Tonix Pharmaceuticals Holding Corp. | €9,3515 | +0,47 % | €153,83M | €331,37K | |
| €7,9189 | -2,70 % | €153,71M | €216,25K | |
DHF BNY Mellon High Yield Strategies Fund | €2,0989 | -0,50 % | €153,42M | €369,83K | |
